Stroke Trial, Recruiting NCT06880978 Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06880978
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have had a procedure to open a blocked heart artery (called PCI) using one of two specific techniques involving the placement of two stents at a branching point in the artery (called mini-crush or controlled balloon-crush)
  • People whose blocked artery is located at a complex branching point in the heart, classified under specific patterns known as Medina 0.1.1 or Medina 1.1.1 (confirm with trial site)

Who may not be able to join:

  • People whose artery branching point does not meet the definition of a "complex" blockage pattern
  • People whose two-stent procedure was performed as an emergency fallback using specific reverse techniques (reverse mini-crush or reverse controlled balloon-crush)
  • People who have had a heart attack involving a complete blockage of blood flow (known as an ST-elevation heart attack)
  • People who are in cardiogenic shock, meaning their heart is not pumping enough blood to meet the body's needs
  • People whose artery has narrowed again inside a previously placed stent (called in-stent restenosis)
  • People who have previously had open-heart bypass surgery
  • People who have had a bare-metal stent (an older type of stent without a drug coating) implanted
  • People with severe, end-stage liver or kidney disease
  • People whose life expectancy is less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 5057705766

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
Registry
ClinicalTrials.gov
Start date
3 March 2025
Est. completion
1 August 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Major adverse cardiac events (MACE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov